EGFR and KRAS mutations in lung carcinoma

The Emerging Role of Biomarkers in Advanced Non–Small-Cell Lung Cancer

(2010) Mark A. Socinski   Clinical Lung Cancer

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

EGFRmutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

(2009) Jason H. Smouse et al.   CANCER CYTOPATHOLOGY

Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

(2009) P. S. Hammerman et al.   CLINICAL CANCER RESEARCH

Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis

(2009) A Fassina et al.   JOURNAL OF CLINICAL PATHOLOGY

Application of COLD-PCR for improved detection of KRAS mutations in clinical samples

(2009) Zhuang Zuo et al.   MODERN PATHOLOGY

Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors

(2009) T John et al.   ONCOGENE

Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma

(2008) S-G. Wu et al.   EUROPEAN RESPIRATORY JOURNAL

ErbBs in lung cancer

(2008) Sreenath V. Sharma et al.   EXPERIMENTAL CELL RESEARCH

Prognostic and Therapeutic Implications of EGFR and KRAS Mutations in Resected Lung Adenocarcinoma

(2008) Jenifer L. Marks et al.   Journal of Thoracic Oncology

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

(2008) Edward S Kim et al.   LANCET

Detection of epidermal growth factor receptor gene mutations in cytology specimens from patients with non-small cell lung cancer utilising high-resolution melting amplicon analysis

(2007) G D Smith et al.   JOURNAL OF CLINICAL PATHOLOGY